BofA lowered the firm’s price target on 4D Molecular (FDMT) to $42 from $46 on Friday and kept a Buy rating on the shares. The firm notes 4D ...

Turpentine is a toxic substance that can cause great harm to an individual's health, particularly when it comes to their ...

Morgan Stanley analyst Judah Frommer lowered the firm’s price target on 4D Molecular (FDMT) to $6 from $8 and keeps an Underweight rating on ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...

Both AS-OCT and Scheimpflug imaging are acceptable imaging modalities for FECD, but they cannot be used interchangeably.

The following is a summary of “Microcystoid macular edema in epiretinal membrane: not a retrograde maculopathy,” published in ...

Drug-induced lung disease cases in France mostly involved ILD, pulmonary edema, and pulmonary fibrosis, largely linked to cancer and CV drugs.

A recent study that compared 2 anti-vascular endothelial growth factor drugs for treating diabetic macular edema (DME) found that brolucizumab (Beovu, Novartis) was non-inferior in functional outcomes ...

Curacle presented the results of its phase 2a clinical trial of CU06 for diabetic macular edema (DME) at the 4th Asia Retina Congress. This meeting is being held alongside the 2024 Annual Meeting of ...

The most frequently reported (>3%) ocular TEAEs were ocular hypertension (9.3%), conjunctival hemorrhage (5.2%), eye pain (4.1%), and cystoid macular edema (3.1%) and the most frequently reported ...